• Media type: E-Article
  • Title: Cx3cr1 controls kidney resident macrophage heterogeneity
  • Contributor: Yashchenko, Alex; Bland, Sarah J.; Song, Cheng J.; Ahmed, Ummey Khalecha Bintha; Sharp, Rachel; Darby, Isabella G.; Cordova, Audrey M.; Smith, Morgan E.; Lever, Jeremie M.; Li, Zhang; Aloria, Ernald J.; Khan, Shuja; Maryam, Bibi; Liu, Shanrun; Crowley, Michael R.; Jones, Kenneth L.; Zenewicz, Lauren A.; George, James F.; Mrug, Michal; Crossman, David K.; Hopp, Katharina; Stavrakis, Stavros; Humphrey, Mary B.; Ginhoux, Florent;
  • imprint: Frontiers Media SA, 2023
  • Published in: Frontiers in Immunology
  • Language: Not determined
  • DOI: 10.3389/fimmu.2023.1082078
  • ISSN: 1664-3224
  • Keywords: Immunology ; Immunology and Allergy
  • Origination:
  • Footnote:
  • Description: <jats:p>Kidney macrophages are comprised of both monocyte-derived and tissue resident populations; however, the heterogeneity of kidney macrophages and factors that regulate their heterogeneity are poorly understood. Herein, we performed single cell RNA sequencing (scRNAseq), fate mapping, and parabiosis to define the cellular heterogeneity of kidney macrophages in healthy mice. Our data indicate that healthy mouse kidneys contain four major subsets of monocytes and two major subsets of kidney resident macrophages (KRM) including a population with enriched <jats:italic>Ccr2</jats:italic> expression, suggesting monocyte origin. Surprisingly, fate mapping data using the newly developed <jats:italic>Ms4a3<jats:sup>Cre</jats:sup> Rosa Stop<jats:sup>f/f</jats:sup> TdT</jats:italic> model indicate that less than 50% of <jats:italic>Ccr2<jats:sup>+</jats:sup></jats:italic> KRM are derived from Ly6c<jats:sup>hi</jats:sup> monocytes. Instead, we find that <jats:italic>Ccr2</jats:italic> expression in KRM reflects their spatial distribution as this cell population is almost exclusively found in the kidney cortex. We also identified <jats:italic>Cx3cr1</jats:italic> as a gene that governs cortex specific accumulation of <jats:italic>Ccr2<jats:sup>+</jats:sup></jats:italic> KRM and show that loss of <jats:italic>Ccr2<jats:sup>+</jats:sup></jats:italic> KRM reduces the severity of cystic kidney disease in a mouse model where cysts are mainly localized to the kidney cortex. Collectively, our data indicate that <jats:italic>Cx3cr1</jats:italic> regulates KRM heterogeneity and niche-specific disease progression.</jats:p>
  • Access State: Open Access